These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29959993)

  • 1. Label-free cell signaling pathway deconvolution of angiotensin type 1 receptor reveals time-resolved G-protein activity and distinct AngII and AngIIIIV responses.
    Lavenus S; Simard É; Besserer-Offroy É; Froehlich U; Leduc R; Grandbois M
    Pharmacol Res; 2018 Oct; 136():108-120. PubMed ID: 29959993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II cyclic analogs as tools to investigate AT
    St-Pierre D; Cabana J; Holleran BJ; Besserer-Offroy É; Escher E; Guillemette G; Lavigne P; Leduc R
    Biochem Pharmacol; 2018 Aug; 154():104-117. PubMed ID: 29684376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers.
    Wilson PC; Lee MH; Appleton KM; El-Shewy HM; Morinelli TA; Peterson YK; Luttrell LM; Jaffa AA
    J Biol Chem; 2013 Jun; 288(26):18872-84. PubMed ID: 23661707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of biased signaling at a G protein-coupled receptor in overexpressed systems.
    Li A; Liu S; Huang R; Ahn S; Lefkowitz RJ
    PLoS One; 2023; 18(3):e0283477. PubMed ID: 36961836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs.
    Zimmerman B; Beautrait A; Aguila B; Charles R; Escher E; Claing A; Bouvier M; Laporte SA
    Sci Signal; 2012 Apr; 5(221):ra33. PubMed ID: 22534132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional selectivity profiling of the angiotensin II type 1 receptor using pathway-wide BRET signaling sensors.
    Namkung Y; LeGouill C; Kumar S; Cao Y; Teixeira LB; Lukasheva V; Giubilaro J; Simões SC; Longpré JM; Devost D; Hébert TE; Piñeyro G; Leduc R; Costa-Neto CM; Bouvier M; Laporte SA
    Sci Signal; 2018 Dec; 11(559):. PubMed ID: 30514808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.
    Cabana J; Holleran B; Leduc R; Escher E; Guillemette G; Lavigne P
    J Biol Chem; 2015 Jun; 290(25):15835-15854. PubMed ID: 25934394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.
    Bosnyak S; Jones ES; Christopoulos A; Aguilar MI; Thomas WG; Widdop RE
    Clin Sci (Lond); 2011 Oct; 121(7):297-303. PubMed ID: 21542804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
    Tang W; Strachan RT; Lefkowitz RJ; Rockman HA
    J Biol Chem; 2014 Oct; 289(41):28271-83. PubMed ID: 25170081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.
    Wang Y; Huang J; Liu X; Niu Y; Zhao L; Yu Y; Zhou L; Lu L; Yu C
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F1-F8. PubMed ID: 28274926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression.
    Ferraino KE; Cora N; Pollard CM; Sizova A; Maning J; Lymperopoulos A
    Cell Signal; 2021 Jun; 82():109967. PubMed ID: 33640432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance.
    Violin JD; DeWire SM; Yamashita D; Rominger DH; Nguyen L; Schiller K; Whalen EJ; Gowen M; Lark MW
    J Pharmacol Exp Ther; 2010 Dec; 335(3):572-9. PubMed ID: 20801892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism.
    Takezako T; Unal H; Karnik SS; Node K
    Pharmacol Res; 2017 Sep; 123():40-50. PubMed ID: 28648738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beta-arrestin pathway-selective type 1A angiotensin receptor (AT1A) agonist [Sar1,Ile4,Ile8]angiotensin II regulates a robust G protein-independent signaling network.
    Kendall RT; Strungs EG; Rachidi SM; Lee MH; El-Shewy HM; Luttrell DK; Janech MG; Luttrell LM
    J Biol Chem; 2011 Jun; 286(22):19880-91. PubMed ID: 21502318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.
    Cao Y; Kumar S; Namkung Y; Gagnon L; Cho A; Laporte SA
    J Biol Chem; 2020 Sep; 295(38):13169-13180. PubMed ID: 32703898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The signaling signature of the neurotensin type 1 receptor with endogenous ligands.
    Besserer-Offroy É; Brouillette RL; Lavenus S; Froehlich U; Brumwell A; Murza A; Longpré JM; Marsault É; Grandbois M; Sarret P; Leduc R
    Eur J Pharmacol; 2017 Jun; 805():1-13. PubMed ID: 28341345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring individual cell-signaling activity using combined metal-clad waveguide and surface-enhanced fluorescence imaging.
    Söllradl T; Chabot K; Fröhlich U; Canva M; Charette PG; Grandbois M
    Analyst; 2018 Nov; 143(22):5559-5567. PubMed ID: 30303502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic code expansion and photocross-linking identify different β-arrestin binding modes to the angiotensin II type 1 receptor.
    Gagnon L; Cao Y; Cho A; Sedki D; Huber T; Sakmar TP; Laporte SA
    J Biol Chem; 2019 Nov; 294(46):17409-17420. PubMed ID: 31530642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin (1-7) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptor.
    Gaidarov I; Adams J; Frazer J; Anthony T; Chen X; Gatlin J; Semple G; Unett DJ
    Cell Signal; 2018 Oct; 50():9-24. PubMed ID: 29928987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-βarrestin-dependent signaling.
    Lymperopoulos A; Borges JI; Carbone AM; Cora N; Sizova A
    Pharmacol Res; 2021 Dec; 174():105943. PubMed ID: 34662735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.